, India
Photo from Envato

India’s coronary stent market to grow at 4% CAGR until 2033

The country accounts for approximately 32% of the Asia-Pacific market in 2024.

India’s coronary drug-eluting stent market is projected to witness a compound annual growth rate of 4% until 2033, due to rising coronary artery disease cases and the demand for advanced treatments.

A report by GlobalData revealed that India accounted for approximately 32% of the Asia-Pacific market in 2024.

One key development is the recent approval granted to Indian manufacturer Sahajanand Medical Technologies by the Australian Therapeutic Goods Administration for its flagship drug-eluting stent, Supraflex Cruz.

The stent, approved in over 80 countries, combines the sirolimus drug with a biodegradable polymer for faster healing and a reduced likelihood of restenosis.

“With increasing foreign interest and a developing domestic market, India has the potential to enhance its role in the global medical device industry,” Kanchan Chauhan, medical devices analyst at GlobalData, said.

 

Follow the links for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.